Greg Mullen

Greg Mullen

Company: Theragnostics

Job title: Chief Executive Officer


Panel Discussion: Opening Up About Funding Challenges in Radiopharmaceuticals 4:30 pm

Highlight issues ranging from funding sources to approaching potential investors Assess the landscape of potential funding sourcesRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.